Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luciano Caprino

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Drug Discovery Today|October 24, 2006
Developing a paradigm of drug innovation: an evaluation algorithmLuciano Caprino, Pierluigi Russo
Annali Dell'Istituto Superiore Di Sanita|July 23, 2005
[Herbal supplements in sports: use and abuse]Luciano Caprino, Maria Cristina Braganò, Francesco Botrè
Journal of Evaluation in Clinical Practice|October 16, 2004
Effectiveness of interferon beta treatment in relapsing-remitting multiple sclerosis: an Italian cohort studyPierluigi Russo, Andrea Paolillo, Luciano Caprino, et al.
Clinical Drug Investigation|May 23, 2007
Cost-analysis of relapsing-remitting multiple sclerosis in Italy after the introduction of new disease-modifying agentsPierluigi Russo, Alessandro Capone, Andrea Paolillo, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Drug Discovery Today|October 24, 2006
Developing a paradigm of drug innovation: an evaluation algorithmLuciano Caprino, Pierluigi Russo
Annali Dell'Istituto Superiore Di Sanita|July 23, 2005
[Herbal supplements in sports: use and abuse]Luciano Caprino, Maria Cristina Braganò, Francesco Botrè
Journal of Evaluation in Clinical Practice|October 16, 2004
Effectiveness of interferon beta treatment in relapsing-remitting multiple sclerosis: an Italian cohort studyPierluigi Russo, Andrea Paolillo, Luciano Caprino, et al.
Clinical Drug Investigation|May 23, 2007
Cost-analysis of relapsing-remitting multiple sclerosis in Italy after the introduction of new disease-modifying agentsPierluigi Russo, Alessandro Capone, Andrea Paolillo, et al.
Pageof 1